Keyword: Kyowa Hakko Kirin
News
08.03.2016
- UK-Swedish drugs maker AstraZeneca has agreed to sell the European rights for Moventig to ProStrakan, a subsidiary of Japanese life sciences company Kyowa Hakko Kirin. The drug is...
News
04.09.2015
- Canadian drugmaker Valeant has said it will work with AstraZeneca on a potential treatment for psoriasis, brodalumab, taking up the gauntlet from Amgen, which recently curtailed...
